Free NanoSight Webinar on the use of Nanoparticle Tracking Analysis in Drug Delivery Research

(Nanowerk News) On Thursday 6th June at 1530 and 1730 BST time (1030 & 1230 EDT), NanoSight will host a webinar to look at how Nanoparticle Tracking Analysis (NTA) is used to as a characterization tool during the development of drug delivery systems. NanoSight will:
  • Discuss drug delivery systems, what’s available and the advantages of nanoparticles.
  • Briefly introduce those unfamiliar to NTA to this technology and the data it provides.
  • Present recent data on the use of NTA in characterizing drug delivery systems of liposomes, polymer carriers and for prodrugs.
  • Drug delivery applications are attractive option as they have the potential to allow a medicine to preferentially act at the site of disease and have reduced side effects. The webinar will discuss how nano-scale therapeutics are particularly suited for drug delivery and what types are available. Particle size is a key parameter when characterizing nano-particles. NTA has been used in the research of drug delivery systems of liposomes, polymer carriers and prodrugs. This webinar will be of particular interest to those working in drug and biotherapeutics research, development and formulation, from Project Managers to Bench Scientists.
    The webinar will be led by Pauline Carnell (Senior Applications Scientist) and Jeremy Warren (CEO). The webinar will be both informative and interactive. Register now and join in the discussions on this important issue: . It will also be available for viewing after the live event. The link will be the same.
    To find out about the company and to learn more about nanoparticle characterization using NanoSight's unique nanoparticle tracking analysis solutions, visit and register to receive the next issue of NanoTrail, the company's electronic newsletter.
    Source: NanoSight (press release)
    Subscribe to a free copy of one of our daily
    Nanowerk Newsletter Email Digests
    with a compilation of all of the day's news.
    These articles might interest you as well: